Galectin Therapeutics Aktie
2,44
EUR
+0,02
EUR
+0,83
%
2,82
USD
+0,05
USD
+1,70
%
Galectin Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Galectin Therapeutics Aktie Analyse
| 13.02.19 | Galectin Therapeutics Buy | B. Riley FBR | |
| 07.12.17 | Galectin Therapeutics Buy | H.C. Wainwright & Co. | |
| 28.11.17 | Galectin Therapeutics Buy | H.C. Wainwright & Co. | |
| 30.03.17 | Galectin Therapeutics Buy | H.C. Wainwright & Co. | |
| 03.10.16 | Galectin Therapeutics Mkt Perform | FBR & Co. | |
| 29.09.16 | Galectin Therapeutics Neutral | H.C. Wainwright & Co. | |
| 28.03.16 | Galectin Therapeutics Buy | H.C. Wainwright & Co. | |
| 21.09.15 | Galectin Therapeutics Buy | H.C. Wainwright & Co. | |
|
Werbung
|
|||
Werbung
Werbung